同仁堂(600085.SH)子公司获得药品GMP证书
格隆汇8月27日丨同仁堂(600085.SH)公布,公司于近日获悉,子公司北京同仁堂科技发展股份有限公司(以下简称同仁堂科技)所属制药厂车间及生产线经过现场检查和技术审核,符合《药品生产质量管理规范》(“GMP”)要求,收到北京市药品监督管理局颁发的《药品GMP证书》。
本次为同仁堂科技所属制药厂原有《药品GMP证书》到期后的再认证,上述车间或生产线通过GMP认证并获得《药品GMP证书》,表明同仁堂科技相关生产线满足GMP要求。本次同仁堂科技获得《药品GMP证书》不会对本公司业绩产生重大影响。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.